Earnings Summary

Treace Medical Concepts Inc’s revenue jumped 25% since last year same period to $62.21Mn in the Q4 2023. On a quarterly growth basis, Treace Medical Concepts Inc has generated 52.64% jump in its revenue since last 3-months.

Treace Medical Concepts Inc’s net profit fell -79.71% since last year same period to $-6.28Mn in the Q4 2023. On a quarterly growth basis, Treace Medical Concepts Inc has generated 64.15% jump in its net profits since last 3-months.

Treace Medical Concepts Inc’s net profit margin fell -43.77% since last year same period to -10.1% in the Q4 2023. On a quarterly growth basis, Treace Medical Concepts Inc has generated 76.51% jump in its net profit margins since last 3-months.

Treace Medical Concepts Inc’s earning per share (EPS) estimates for the current quarter stand at -0.3 - a -233.33% fall from last quarter’s estimates.

Treace Medical Concepts Inc’s earning per share (EPS) estimates for the current year stand at -0.3.

Treace Medical Concepts Inc’s earning per share (EPS) fell -25% since last year same period to -0.1 in the Q4 2023. This indicates that the Treace Medical Concepts Inc has generated -25% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Treace Medical Concepts Inc’s return on assets (ROA) stands at -0.16.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Treace Medical Concepts Inc’s return on equity (ROE) stands at -0.5.